Glatz Torben, Brinkmann Sebastian, Thaher Omar, Driouch Jamal, Bausch Dirk
Chirurgische Klinik, Marien Hospital Herne - Universitätsklinikum der Ruhr-Universität Bochum, Herne, Deutschland.
Zentralbl Chir. 2022 Apr;147(2):188-195. doi: 10.1055/a-1750-9779. Epub 2022 Apr 4.
Minimally invasive resection techniques for the treatment of various pathologies of the pancreas are potentially advantageous for the treated patients in terms of restitution time and postoperative morbidity, but are a technical challenge for the responsible surgeon. The introduction of robotic assistance in visceral surgery offers a possibility for further distribution of minimally invasive procedures in pancreatic surgery.The aim of this study was to examine the possibilities for developing robotic pancreatic surgery in Germany. The data are based on the quality reports of the hospitals for the years 2015-2019 combined with a selective literature search.The number of quality reports available decreased from 1635 to 1594 between 2015 and 2019. A median of 96 clinics performed 11-20, 56 clinics 21-50 and 15 clinics more than 50 pancreaticoduodenectomies. For distal resections, there were 35 clinics with 11-20, 14 clinics with 21-50 and two clinics with more than 50 procedures. In relation to all clinics with at least five distal resections per year, minimally invasive procedures were performed at only 29 clinics; a ratio to laparoscopic left resections of over 50% was reported in only seven clinics.According to the literature, the learning curves for robotic pancreatic distal resection and pancreaticoduodenectomy diverge. While the learning curve for robotic distal resection is completed after around 20 procedures, the learning curve for robotic pancreaticoduodenectomy has several plateaus, which are reached after around 30, 100 and 250 procedures.Due to the decentralised structure of pancreatic surgery in Germany, a nationwide introduction of robotic pancreatic surgery is unlikely. The routine use of robotic pancreaticoduodenectomy will probably be restricted to high volume centres in the foreseeable future.
用于治疗胰腺各种病变的微创切除技术,在恢复时间和术后发病率方面,对接受治疗的患者可能具有潜在优势,但对主刀医生来说是一项技术挑战。机器人辅助在内脏手术中的引入,为胰腺手术中进一步推广微创手术提供了可能。本研究的目的是探讨在德国开展机器人胰腺手术的可能性。数据基于2015 - 2019年各医院的质量报告,并结合了选择性文献检索。2015年至2019年间,可用质量报告的数量从1635份降至1594份。中位数为96家诊所进行了11 - 20例胰十二指肠切除术,56家诊所进行了21 - 50例,15家诊所进行了超过50例。对于远端切除术,有35家诊所进行了11 - 20例,14家诊所进行了21 - 50例,两家诊所进行了超过50例手术。在每年至少进行5例远端切除术的所有诊所中,只有29家诊所开展了微创手术;只有7家诊所报告腹腔镜左切除术的比例超过50%。根据文献,机器人胰腺远端切除术和胰十二指肠切除术的学习曲线有所不同。机器人远端切除术的学习曲线在大约20例手术后完成,而机器人胰十二指肠切除术的学习曲线有几个平台期,分别在大约30例、100例和250例手术后达到。由于德国胰腺手术的分散结构,在全国范围内引入机器人胰腺手术不太可能。在可预见的未来,机器人胰十二指肠切除术的常规使用可能会局限于高手术量的中心。